Skip to content
Recall Observatory FDA recall evidence

Drug product

Livalo (pitavatstatin) tablets, 4 mg, 90-count bottles, Rx only, Manufactured by: Patheon, Inc. Cincinnati, OH 45237 USA or by Kowa Company, Ltd, Nagoya, 462-0024 Japan, Marketed by Kowa Pharmaceuticals: Kowa Pharmaceuticals America Inc., Montgomery, AL 36117 USA NDC 66869-404-90 HDPE Bottle, congregated into a shrink wrapped 6-pack further congregated into 24 6-packs in a cardboard case

D-0258-2025

February 24, 2025

Class III

Product summary

Firm
Kowa Pharmaceuticals America
Event
Event 96379
Status
Completed
Classification
Class III
Quantity
5,328 Bottles
Official record key
drug-enforcement:D-0258-2025

Official wording

Reason: Presence of foreign tablets/capsules

Code information: Lot#: 3231300, Exp 8/2027

Distribution pattern: PA, OH, and TX

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    foreign tablets